Table 1.
Demographic and clinical characteristics of 45 HIV-1 & HSV-2-seropositive persons.
| Session 1 N=45 (%) |
Session 2 N=34 (%) |
Session 3 N=26 (%) |
|
|---|---|---|---|
| Age, median (range) | 41 (20–64) | 41 (29–64) | 42 (29–64) |
| White Race | 35 (78) | 25 (74) | 20 (77) |
| Men | 38 (84) | 29 (85) | 23 (88) |
| Men who have sex with men | 37 (82) | 28 (82) | 22 (85) |
| Prior history of genital herpesa | 38 (84) | 30 (88) | 22 (85) |
| Serostatus | |||
| HSV-1 & HSV-2 | 30 (67) | 26 (76) | 21 (81) |
| HSV-2 only | 15 (33) | 8 (23) | 5 (19) |
| Days with swabs, median (range) | 62 (34–176) | 62.5 (36–69) | 63 (30–79) |
| Days with valid diary, median (range)b | 63 (0–176) | 66 (0–93) | 66 (0–84) |
| Persons on ART | 30 (67) | 26 (76) | 24 (92) |
| CD4+ count (cells/mm3)c | |||
| ≤200 | 12 (27) | 13 (38) | 6 (23) |
| 201 – 350 | 16 (36) | 7 (21) | 8 (31) |
| >350 | 17 (38) | 14 (41) | 12 (46) |
| HIV RNA (copies/mL)c | |||
| undetectabled | 11 (24) | 8 (23) | 7 (27) |
| 51 – 1,000 | 12 (27) | 8 (23) | 5 (19) |
| 1,001 – 10,000 | 7 (16) | 9 (26) | 8 (31) |
| >10,000 | 15 (33) | 9 (26) | 6 (23) |
a
as determined by self-report
b
one person in each session did not provide diary information
c
at time closest to onset of observation session (within 60 days)
d
<50 copies/mL